The PD-1:PD-L immunoregulatory pathway has major roles in controlling exhausted/dysfunctional T cells and this pathway has become a major clinical target in cancer and chronic infection. The role of this pathway in acute infections is unclear. Available data are conflicting, but have focused on effector CD8 T cell expansion. Our new exciting preliminary data identify a novel and major role for the PD-1:PD-L pathway as a key integrator of signals that result in optimal CD8 T cell memory quality. Specifically, we have found that the PD-1 pathway shapes effector and memory CD8 T cell differentiation during acute influenza (Flu) infection. These findings give impetus to investigating how PD-1 and its ligands control CD8 T cell differentiation following acute infections. Thus, we will define mechanisms by which the PD-1 pathway regulates effector CD8 T cell differentiation and development of memory CD8 T cells during Flu infection. There is a tremendous need for new or improved vaccines against respiratory pathogens such as Flu. However, it has been challenging to harness the potential of T cell-based vaccines for respiratory viral infections partly due to limited knowledge of how to effectively induce the most protective types of memory T cells. Determining how PD-1 promotes CD8 T cell memory may generate a better understanding of protective immunity to Flu and enable novel vaccine strategies for other respiratory viruses. In Project 2 we will interrogate where and when PD-1 pathway signals are important for effector and memory CD8 T cell development, which interactions within the PD-1 pathway are involved and which APCs deliver these signals, and how these events are integrated with the downstream transcription factors T-bet and Eomes. We will test the hypothesis that, rather than simply inhibiting responses, the PD-1:PD-L pathway acts as a rheostat regulating cell fate decisions of CD8 T cells and long-term immunity to acute viral infection. We will test this hypothesis through the following Aims:
Aim 1 : To test the hypothesis that the PD-1 pathway regulates early T cell activation dynamics during priming.
Aim 2 : To test the hypothesis that the PD-1 pathway regulates effector CD8 T cell differentiation and function after priming, and define when and where this regulation occurs.
Aim 3 : To test the hypothesis that the PD-1 pathway affects CD8 T cell memory via altering homeostasis and regulating novel memory T cell subsets and Eomes. Studies in P2 will synergize with those in P1 and P3 given a major interest in P1 and P2 on subsets of memory CD8 T cells and the role of T-bet. P1, P2 and P3 also have a strong interest sin homing and migration as well as the PD-1 pathway creating a common set of shared themes. Finally, key studies on early priming events and homing and migration will be enabled through Core B.
|Deruaz, Maud; Murooka, Thomas T; Ji, Sophina et al. (2017) Chemoattractant-mediated leukocyte trafficking enables HIV dissemination from the genital mucosa. JCI Insight 2:e88533|
|Herati, Ramin Sedaghat; Muselman, Alexander; Vella, Laura et al. (2017) Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells. Sci Immunol 2:|
|Chen, Zeyu; Stelekati, Erietta; Kurachi, Makoto et al. (2017) miR-150 Regulates Memory CD8 T Cell Differentiation via c-Myb. Cell Rep 20:2584-2597|
|Jones, R Brad; Mueller, Stephanie; Kumari, Sudha et al. (2017) Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cells. Biomaterials 117:44-53|
|Thiriot, Aude; Perdomo, Carolina; Cheng, Guiying et al. (2017) Differential DARC/ACKR1 expression distinguishes venular from non-venular endothelial cells in murine tissues. BMC Biol 15:45|
|Barnett, Burton E; Staupe, Ryan P; Odorizzi, Pamela M et al. (2016) Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection. J Immunol 197:1017-22|
|Deruaz, Maud; Moldt, Brian; Le, Khoa M et al. (2016) Protection of Humanized Mice From Repeated Intravaginal HIV Challenge by Passive Immunization: A Model for Studying the Efficacy of Neutralizing Antibodies In Vivo. J Infect Dis 214:612-6|
|Urso, Katia; Alvarez, David; Cremasco, Viviana et al. (2016) IL4RA on lymphatic endothelial cells promotes T cell egress during sclerodermatous graft versus host disease. JCI Insight 1:|
|Attanasio, John; Wherry, E John (2016) Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease. Immunity 44:1052-68|
|Wheeler, Lee Adam; Trifonova, Radiana T; Vrbanac, Vladimir et al. (2016) TREX1 Knockdown Induces an Interferon Response to HIV that Delays Viral Infection in Humanized Mice. Cell Rep 15:1715-27|
Showing the most recent 10 out of 40 publications